An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• Maintaining genome integrity is crucial for cellular health.
• E2F7's role in DNA damage response and cell cycle regulation is not fully understood.
• Genotoxic damage can lead to replication stress and genomic instability.

Purpose of the Study:

• To elucidate the function of E2F7 in cellular responses to genotoxic damage.
• To investigate E2F7's impact on DNA repair pathways and genomic stability.
• To determine the therapeutic implications of E2F7 modulation.

Main Methods:

• Gene knockdown experiments (E2F7 depletion).
• Analysis of DNA repair foci (53BP1, FANCD2) and chromosomal aberrations.
• Cell-cycle re-entry and clonogenic survival assays.
• p53-independence assessment.
• Homologous recombination assays via RAD51 expression analysis.

Main Results:

• E2F7 represses genes essential for genomic stability, including RAD51.
• E2F7 knockdown reduces DNA repair foci and chromosomal aberrations after interstrand crosslink (ICL) damage.
• E2F7 depletion enhances cell survival and re-entry after ICL-inducing agent exposure.
• E2F7's activity in this context is p53-independent.
• Downregulation of E2F7 increases resistance to chemotherapy in recombination-deficient cells.

Conclusions:

• E2F7 controls a transcriptional program regulating DNA repair and genomic integrity.
• E2F7 acts as a repressor of homologous recombination and genomic stability.
• Targeting E2F7 may offer therapeutic strategies for enhancing chemotherapy efficacy, particularly in recombination-deficient cancers.